Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (171-180 of 528) with videos related to

Pageof 53
Sort By:
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
Journal of Biosciences|October 12, 2022
Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networksSrisairam Achuthan, Rishov Chatterjee, Sourabh Kotnala, et al.
Cancer Research|June 17, 2005
Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2Fei Chu, John Barkinge, Sarah Hawkins, et al.
Anesthesiology|February 21, 2012
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasisFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Archives of Pathology & Laboratory Medicine|November 4, 2010
Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lungJie Song, Mei Li, Maria Tretiakova, et al.
Clinical and Translational Medicine|March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategiesJun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.
Current Proteomics|June 8, 2010
DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCERAnkur Shah, Harpreet Singh, Vibhu Sachdev, et al.
Cytokine & Growth Factor Reviews|December 26, 2001
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibitionGautam Maulik, Amol Shrikhande, Takashi Kijima, et al.
Growth Factors (Chur, Switzerland)|November 14, 2014
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibitionBenjamin D Ferguson, Maria S Tretiakova, Mark W Lingen, et al.
Cancers|March 11, 2023
Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung CancerReza Zarinshenas, Arya Amini, Isa Mambetsariev, et al.
Pageof 53

Showing results (171-180 of 528) with videos related to

Sort By:
Pageof 53
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
Journal of Biosciences|October 12, 2022
Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networksSrisairam Achuthan, Rishov Chatterjee, Sourabh Kotnala, et al.
Cancer Research|June 17, 2005
Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2Fei Chu, John Barkinge, Sarah Hawkins, et al.
Anesthesiology|February 21, 2012
Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasisFrances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Archives of Pathology & Laboratory Medicine|November 4, 2010
Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lungJie Song, Mei Li, Maria Tretiakova, et al.
Clinical and Translational Medicine|March 20, 2019
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategiesJun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, et al.
Current Proteomics|June 8, 2010
DIFFERENTIAL SERUM LEVEL OF SPECIFIC HAPTOGLOBIN ISOFORMS IN SMALL CELL LUNG CANCERAnkur Shah, Harpreet Singh, Vibhu Sachdev, et al.
Cytokine & Growth Factor Reviews|December 26, 2001
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibitionGautam Maulik, Amol Shrikhande, Takashi Kijima, et al.
Growth Factors (Chur, Switzerland)|November 14, 2014
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibitionBenjamin D Ferguson, Maria S Tretiakova, Mark W Lingen, et al.
Cancers|March 11, 2023
Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung CancerReza Zarinshenas, Arya Amini, Isa Mambetsariev, et al.
Pageof 53